Kiora Pharmaceuticals (KPRX)
(Delayed Data from NSDQ)
$3.15 USD
-0.09 (-2.78%)
Updated Aug 13, 2024 04:00 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.66 |
EPS Last Quarter | -0.53 |
Last EPS Surprise | 44.21% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.04 |
Next Year | -2.55 |
EPS (TTM) | NA |
P/E (F1) | 3.04 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 16.00M | NA |
# of Estimates | NA | NA | 1 | NA |
High Estimate | NA | NA | 16.00M | NA |
Low Estimate | NA | NA | 16.00M | NA |
Year ago Sales | 0.00M | NA | NA | 16.00M |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.66 | -0.65 | 1.04 | -2.55 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | -0.66 | -0.65 | 1.31 | -2.66 |
High Estimate | -0.66 | -0.65 | 1.31 | -2.43 |
Low Estimate | -0.66 | -0.65 | 0.76 | -2.66 |
Year ago EPS | -8.01 | NA | -24.21 | 1.04 |
Year over Year Growth Est. | 91.76% | NA | 104.30% | -344.24% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.66 | -0.65 | 1.04 | -2.55 |
7 Days Ago | -0.66 | -0.65 | 0.97 | -2.55 |
30 Days Ago | -0.72 | -0.72 | 0.99 | -2.75 |
60 Days Ago | -0.72 | -0.72 | 0.99 | -2.75 |
90 Days Ago | -0.72 | -0.81 | 0.95 | -2.43 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.66 | -0.65 | 1.04 | -2.66 |
Zacks Consensus Estimate | -0.66 | -0.65 | 1.04 | -2.55 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -4.52% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.53 | 3.42 | NA | -8.01 | NA |
Estimate | -0.95 | 5.58 | NA | -2.70 | NA |
Difference | 0.42 | -2.16 | NA | -5.31 | -2.35 |
Surprise | 44.21% | -38.71% | NA | -196.67% | -63.72% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more